Miulli General Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2021
NCT04583813
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Miulli General Hospital